CG Oncology (NASDAQ:CGON) Price Target Raised to $56.00
CG Oncology (NASDAQ:CGON – Get Free Report) had its target price hoisted by investment analysts at Morgan Stanley from $52.00 to $56.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Morgan Stanley’s target price would indicate a potential upside of 113.09% from the stock’s current price. […]
CG Oncology (NASDAQ:CGON – Get Free Report) had its target price hoisted by investment analysts at Morgan Stanley from $52.00 to $56.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Morgan Stanley’s target price would indicate a potential upside of 113.09% from the stock’s current price. […]
